Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer

NCT07630558 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT07630558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07630558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 1997
Completion date
October 15, 2026
Enrollment
1,891 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer